As of 2025-10-18, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (74.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2907.2%.
The range of the Relative Valuation is (73.79) - (78.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.5x - 33.0x | 29.9x |
| Forward P/E multiples | 30.9x - 34.0x | 32.4x |
| Fair Price | (73.79) - (78.71) | (74.39) |
| Upside | -2884.6% - -3070.3% | -2907.2% |
| Date | P/E |